BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2237156)

  • 1. [Serous tumors of the ovary with limited malignancy. Current analysis of a review of the international literature apropos of a case].
    Lethai N; Bouquet de Jolinière J; Senèze J
    Rev Fr Gynecol Obstet; 1990; 85(7-9):467-72. PubMed ID: 2237156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: case report.
    Attar E; Berkman S; Topuz S; Baysal B; Akhan S; Chambers JT
    Hum Reprod; 2004 Jun; 19(6):1472-5. PubMed ID: 15105388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic carcinoma metastasis to ovary having serous cystadenocarcinoma -- an unusual case of double ovarian malignancy.
    Visweswara RN; Prabhu VM
    Cent Afr J Med; 1995 Nov; 41(11):357-9. PubMed ID: 8932579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral micropapillary serous carcinoma of the ovary: a case report.
    Gupta R; Singh S; Nigam S
    Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormonally-active ovarian tumors in 30 years of data (1965-1994)].
    Molnar E; Sloboda L; Fenjvesi A; Zivković S
    Med Pregl; 1999; 52(6-8):241-5. PubMed ID: 10518380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
    Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
    Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Scully RE
    Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of borderline tumors of the ovary: state of the art.
    Tropé C; Kaern J
    Semin Oncol; 1998 Jun; 25(3):372-80. PubMed ID: 9633850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between serious ovarian tumors and extra-ovarian peritoneal tumors of the same histology].
    Kunz J; Rondez R
    Praxis (Bern 1994); 1998 Feb; 87(6):191-8. PubMed ID: 9531813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
    Tan Y; Sinniah R; Bay BH; Singh G
    J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial ovarian tumors in children: a retrospective analysis.
    Morowitz M; Huff D; von Allmen D
    J Pediatr Surg; 2003 Mar; 38(3):331-5; discussion 331-5. PubMed ID: 12632344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
    Fu YS; Ro J; Reagan JW; Hall TL; Berek J
    Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
    Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current issues in the pathology of ovarian cancer.
    Rabban JT; Bell DA
    J Reprod Med; 2005 Jun; 50(6):467-74. PubMed ID: 16050571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of stromatosis uteri].
    Tischendorf T; Dörste P
    Zentralbl Gynakol; 1987; 109(16):1038-41. PubMed ID: 3673325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic subtypes and laterality of primary epithelial ovarian tumors.
    Boger-Megiddo I; Weiss NS
    Gynecol Oncol; 2005 Apr; 97(1):80-3. PubMed ID: 15790441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.